Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
Depixus raised $35.4 million series A co-led by Lansdowne Partners and the PSIM Fund.

Depixus raised $35.4 million series A co-led by Lansdowne Partners and the PSIM Fund.

Biotech Manufacturing

France

United Kingdom

United States

Investments

15 December 2021

Share:

Depixus (company)

France

Biotech Manufacturing

Total investments received (USD): 35.4m

Round value (USD): 35.4m

Round investors: Arix Bioscience plc Bpifrance Casdin Capital Lansdowne Partners

Company: Depixus

Industry: Biotech Manufacturing

Related deals

Domain Therapeutics raised $42 million in Series A funding co-led by Panacea Ventures, CTI Life Sciences and 3B Future Health Fund.

Biotech Health services Manufacturing

France

United Kingdom

Luxembourg

Belgium

Canada

China

Investments 08 May 2022

Xenothera in a €20 million funding round led by the European fund EIC Fund and the Nabuboto holding company.

Biotech Health services Manufacturing

France

Belgium

Investments 28 June 2021

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top